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Burns are known to have an effect on coagulation in the early post burn period.  
Current coagulation tests have been criticised in acute burns due to their inherent 
limitations. This study aims to investigate the potential for a new quantitative 
functional biomarker of clot quality, fractal dimension, to identify changes in clot 
microstructure as a result of the burn inflammatory response and its treatment. 
Methods: 
A total of fifty-eight burn patients were included in this prospective case-controlled 
study. The control group (29 patients mean TBSA 1%), and case group (29 patients 
mean TBSA 30%) were compared at baseline and the case group investigated further 
over four time points (baseline, 12 hours, 24 hours and 5-7 days). Fractal analysis 
was performed, as well as current markers of coagulation, inflammatory markers 
and point-of-care tests, Thromboelastography and Multiplate analysis. 
Results: 
Fractal dimension did not differ between groups at admission (1.73 ± 0.06 and 1.72 ± 
0.1), and fell within the healthy index normal range (1.74 ± 0.7), suggesting a normal 
clot microstructure in the early post burn period. Fractal dimension significantly 
reduced from baseline over the first 24 hours post burn (1.59 ± 0.03 p <0.005), 
indicating a significant reduction in mechanical clot strength and functionality 
consistent with a hypocoagulable state, not identified with other markers. 
Conclusions: 
This is the first study to quantify the changes in clot microstructure following burn 
injury. This study confirms clot microstructure is significantly altered during the first 
24 hours post burn, with the production of a weaker, more porous fibrin clot, 
consistent with a hypocoagulable state. 
 




Burn injury involves a complex interplay between early activation of uncontrolled 
coagulation and fibrinolysis, coupled with increases in inflammatory mediators [1-3]. 
Alterations in the coagulation system contribute to the progression of organ failure 
and increased morbidity and mortality in burns patients [4-7]. A combination of 
reducing blood loss and tailoring blood product administration could improve 
patient outcome and reduce mortality. Accurate and early identification of 
coagulation abnormalities is essential in reducing morbidity and mortality. Clinical 
markers (PT and APTT) are commonly used for monitoring anticoagulation, however 
they do not represent a global picture of coagulation and are insensitive to acute 
alterations in coagulation defects [8,9]. Point-of-care tests of coagulation, such as 
rotational thromboelastometry (ROTEM), which provides bedside information on 
clot development and fibrinolysis, are increasingly used in the clinical setting. 
Recent rheological studies have highlighted the ability to scientifically and accurately 
quantify the quality and arrangement of clot microstructure that occur during clot 
development by measuring its fractal dimension (Df) [10]. Df has demonstrated a 
significant effect of changes in temperature and fluid dilution on clot microstructure 
[11-13] and more recently in clinical studies, to detect abnormal clot microstructure 
in response to the inflammatory changes seen in cancer, stroke and sepsis patients, 
even when standard laboratory tests have not [14-16]. The effect of burn injury on 
clot microstructure and clot quality has not previously been quantified. This study 
aims to quantify for the first time, the changes in clot microstructure as a result of 
burn injury, and to assess changes following pathophysiological progression and 
therapeutic intervention in the early post-burn period.  
 
2. METHODOLOGY 
2.1 Study design & ethical approval 
The single centre, prospective, case-controlled study was approved by the South 
West Wales Research Ethics Committee (07/WMW02/34). This study was performed 
in the emergency department and regional burns centre of a large teaching hospital. 
Informed two-stage written consent was sought before enrolment to the study, 
unless capacity was lacking (e.g. acute transfer sedated/intubated) in which case 
assent was sought from legal, personal or professional representatives.  
 
2.2 Recruitment of burns patients 
Inclusion criteria included patients aged over 18 years, presenting within 24 hours of 
a cutaneous burn injury. Exclusion criteria included patients admitted without 
cutaneous burns e.g. pure inhalational injury; patients presenting after 24 hours; 
patients with known co-morbidities affecting coagulation e.g. liver disease, 
malignancy; and any patient on anticoagulant medication. Patients with total body 
surface area (TBSA) 3% and below were classified into the control group, patients 
with 6% TBSA burns and over made up the case group. All patients had baseline 
blood samples (time point 0), and the case group had a maximum of three further 
samples, at time points 1 (6-12 hours post first sample), 2 (at 24 hours) and 3 (5 – 7 
days) to assess the effect of pathophysiological progression and continuing 
therapeutic intervention. Patient demographics and details of injury were collected 
at enrolment. Case group patient had details of interventions and therapy recorded 
until their final sample point at 5-7 days post burn. 
 
2.3 Blood Sampling 
A 20ml blood sample was obtained atraumatically from either venepuncture using 
an 18-gauge needle and syringe, or via an arterial/central venous line when one was 
already in place. The first 5mL of blood was discarded and the following 9mL was 
immediately transferred into the rheometer for rheological analysis. Further blood 
was drawn into an EDTA vacutainer (Becton, Dickinson and Company, UK, Ref: 
367839) and a 3.2 % sodium citrate vacutainer (Greiner Bio-One GmbH, Austria, Ref: 
454327) for standard laboratory markers of coagulation, and further samples were 
collected for ROTEM and Multiplate analysis. 
 
2.4 Gel Point and Fractal Dimension measurements 
Gel point analysis was performed using a TA Instruments AR-G2 controlled-stress 
rheometer (TA Instruments, New Castle, DE, USA). This technique detects the gel 
point, from which the time to gel point (TGP), G′GP  (a measure of the 
strength/elasticity of the incipient clot, and fractal dimension (Df) of the fibrin clot 
are derived. This methodology used has been described in greater detail previously 
[10,11,17]. 
 
2.5 Standard laboratory tests 
Haematological profile was analysed on a Sysmex XE 2100 (TOA Medical Electronics) 
automated haematology analyzer and routine clotting tests were undertaken using a 
Sysmex CA1500 analyzer (Siemens), within 2 hours of collection. D-dimers were 
measured using the TriniLIA Auto-Dimer® turbidimetric assay with a Sysmex CA1500, 
and is reported as either a positive or negative result. Factor VIII was determined 
using an aPTT-based one-stage assay using appropriate factor deficient plasma and 
Actin FS APTT reagent (Siemens Healthcare Diagnostics Products GmbH, Marburg, 
Germany).  
 
2.6 Inflammatory markers 
The inflammatory markers IL-6, TNF-α and Procalcitonin (PCT) were chosen to 
measure inflammation based on previous literature on the effect of burns18-20. 
Concentrations of each marker were measured in platelet poor plasma using 
enzyme-linked immunosorbent assay (ELISA) kits for IL-6, TNF-α and PCT. All 
materials were equilibrated to room temperature (18 – 25oC) prior to use, and the 
standard procedure supplied was followed. 
 
2.7 Rotational Thromboelastometry 
Thromboelastometry was performed using a ROTEM delta whole blood haemostasis 
system and blood was activated by both intrinsic (INTEM) and extrinsic (EXTEM) 
activation. Tests were carried out in accordance with the manufacturer’s 
recommendations. The Clotting Time (CT), Maximum Clot Firmness (MCF) and 
Maximum Lysis (ML) were recorded to assess the kinetic, structural and fibrinolytic 




2.8 Whole blood platelet aggregometry (Multiplate) 
Hirudinised blood was transferred 20 minutes after sampling to the Multiplate test 
cell (Roche Diagnostics GmbH, Mannheim, Germany, REF: 06675590), followed by 
500μL of normal saline and then left to incubate for three minutes in individual test 
cells. The appropriate agonist (Adeonsine Diphosphate (ADP), Arachadonic acid 
(ASPI) and collagen (Coll)) was then added to the test cells using an automated 
pipette system. The area under the curve (AUC) was calculated, and reported as 
arbitrary aggregation units (U). 
 
2.9 Blood clot imaging: scanning electron microscopy (SEM)  
SEM samples were prepared from 21 μL of whole blood using the methodology 
described previously 15. The resultant dehydrated blood samples were coated with 
gold palladium and then imaged using a Hitachi ultra- high resolution FE-SEM S-4800.  
 
2.10 Sample size 
The primary outcome of this study was to investigate the hypothesis that Df will be 
increased in subjects with a greater than 6% burn area as compared with those less 
than 3% and that therapeutic intervention will result in a further modulation in Df in 
the subjects with greater than 6% burns. Data from previous studies suggests we 
would expect a difference in Df of at least 0.03 and an SD of 0.04 in the case group as 
compared with the smaller control burns with essentially normal coagulation. Using 
these figures as the basis of calculation, a two-sample t-test to detect between 
group differences at baseline α= 0.8 and significance level of 0.05 we calculated two 
samples of 29 required to undertake this study.  
 
2.11 Statistical analysis 
Statistical analysis was performed using Minitab® version 16 software (Havertown, 
PA). Between group differences was determined at baseline using the two-sample t-
test for normally distributed and the Mann-Whitney test for non-normally 
distributed data. Within group analysis was undertaken on the case group to 
determine the effect of therapeutic intervention on the various markers using one-
way ANOVA on normally distributed data and Kruskal-Wallis for non-normally 
distributed data. Correlations were investigated using Pearson’s method for 
normally distributed and Spearman’s method for non-normally distributed data. 
Statistical significance was defined as p<0.05 throughout. 
 
3. RESULTS 
3.1 Baseline characteristics of groups 
The baseline characteristics including demographics and burn injury details are 
shown in Table 1. Fifty-eight patients were included in the study, comprising 29 in 
each group. The patient demographics were well matched between groups, and the 
baseline burn characteristics reflected the more severe burns in the case group, with 
a higher total body surface area burn (% TBSA), full thickness burns (% FTB), more 
inhalation injuries, higher volume of fluid resuscitation and mortality rate.  
 
3.2 Changes in standard laboratory markers between groups 
The results for the standard laboratory tests, inflammatory markers, ROTEM, 
Multiplate and rheological data for both groups at baseline are presented in Table 2. 
The white cell count was significantly higher (p<0.005) in the case group, compared 
to the controls. Haemaglobin and haemaocrit did not differ significantly. The 
standard kinetic markers of coagulation, PT (p<0.005) and APTT (p = 0.015) were 
significantly prolonged in the case group, however both fell within the normal limits. 
Fibrinogen levels were within the normal range for both groups and did not differ 
significantly. Factor VIII (FVIII) activity was significantly increased (p<0.01) in the case 
group, and above the normal range. There were a significantly higher proportion of 
patients in the case group (86%) compared to the control group (63%) with a positive 
D-dimer result, indicating both increased clot activity and breakdown in the case 
group.  
 
All of the inflammatory markers were significantly elevated in the case group, 
indicating a more marked inflammatory response in the larger burns.  
 
Significant changes were seen in all ROTEM parameters between the two groups, 
except for CT and MCF activated with INTEM. These results suggest the case group 
produced a weaker clot, with less kinetic activity resulting in a prolonged clotting 
time than the control group. However, all results for both groups fell within the 
normal ROTEM parameters, so although there was a significant difference between 
groups, the ROTEM did not identify a coagulopathy in the case group. 
 
All of the platelet aggregometry results were significantly reduced in the case group, 
and were below the normal range in the ADP and ASPI tests, whereas the control 
groups fell within the normal range. 
 
Df did not significantly differ, and both groups fell within the normal range at 
admission, which has been determined from previous studies 10. The TGP was shorter 
in the case group, although not significant, and the G’GP was significantly lower (p = 
0.002) in the case group. This indicates that the case group produced structurally 
weaker clots, with less elasticity than the controls. 
 
3.3 Changes in markers over time in the case group 
The changes in the case groups routine coagulation markers and Df over the four 
time points, are demonstrated in Figure 1. APTT and fibrinogen levels significantly 
increased over time, with fibrinogen levels peaking at 5-7days. Although APTT levels 
changed significantly over time, they reached their highest at 24hours and appeared 
to be decreasing again by 5-7 days. PT and the proportion of positive D-dimer levels 
did not alter significantly over time. Factor VIII significantly decreased over the first 
24hours but then was increased well above baseline at 5-7days. CRP was the only 
inflammatory marker that showed significant changes over the study period, with a 
gradual increase from admission to one week (21 ± 5 to 219.8 ± 17.9, p<0.005). 
There was little change observed in the other inflammatory markers over the four 
time periods. 
 
Of the ROTEM parameters, only MCF and CT showed a significant change over time. 
There was a significant increase in the kinetic properties of clot formation, 
demonstrated by increasing CT. Significant reductions in the structural properties of 
the clot were demonstrated over the first 24 hours by a reduction in MCF, however 
even at its lowest, it was still within the normal range. MCF results had returned to 
above baseline by 5-7 days. All ROTEM parameters were within normal limits for the 
duration of the study. 
 
The only Multiplate parameter that showed a significant change was ADP-AUC. 
There was a significant reduction in platelet activity using the ADP to activate, seen 
in the first 24 hours, which then had increased above baseline by 5 – 7 days. The 
same pattern was mirrored in all other parameters, however they did not reach 
significance. These results demonstrate platelet activity reduces over the first 24 
hours following burn injury, but then by a week post burn, activity has returned to 
levels above baseline and to a level within or close to the normal range. 
 
There was a significant change in Df over time. Df reduced significantly over the first 
24hours, to a mean of 1.59, which is well below the normal range for a healthy clot, 
but appeared to be increasing back towards baseline by 5-7 days.  
 
There was a significant change from baseline in the volume of fluid given as time 
progressed, with the highest volume being given prior to the first sample. Figure 2 
demonstrates the changes in Df over the four time periods in response to total fluid 
volume and volume of colloid given over the four time points. 
 
3.4 Clot imaging: Scanning Electron Microscopy 
Previous studies have demonstrated the relationship between Df and fibrin fibre 
width as measured with SEM, particularly in inflammatory conditions whereby fibre 
width decreased with decreasing Df in more severe inflammatory states, such as 
septic shock [12,14,16]. Scanning Electron microscopy (SEM) was used to image the 
mature clots of a single patient from the case group over three time points for 
illustrational purposes, to demonstrate the fibrin structure observed and the 
corresponding Df (Figure 3). The images illustrate the change in clot microstructure, 
with a denser clot with more branch points corresponding to a Df of 1.69, to a 
porous clot with fewer fibrin fibres and branch points, corresponding to a Df of 1.39. 
 
4. DISCUSSION 
Previous studies have demonstrated Df to be an accurate method of quantifying the 
developing and final clot architecture in a number of conditions. Increased Df is 
associated with hypercoagulable states with increased clot strength and more 
densely formed clots, seen in inflammatory and vascular conditions, such as sepsis, 
lung cancer and stroke [14-16]. Reduced Df is associated with hypocoagulable states, 
with weakened clot properties, such as in septic shock and with the use of 
anticoagulants [10,16]. This study demonstrates for the first time that the 
mechanical properties of the clot in both the hyper- and hypo-coagulable phases 
after burn injury can be quantified using Df as a functional biomarker of clot 
microstructure. 
 
This study demonstrated no difference in clot microstructure between smaller and 
larger burns at admission, with Df falling within normal limits in both groups and a 
normal standard coagulation profile in both at baseline. This correlated with 
previous literature, which suggests that burn patients do not exhibit a coagulopathy 
at presentation based on routine coagulation markers [4,21,22]. Thereafter, in the 
larger burn group, Df significantly reduced over the next 24 hours, corresponding to a 
hypocoagulable state, with formation of a loose and structurally weaker clot that 
would potentially be more prone to fibrinolysis. One previous study of patients with 
>20% TBSA found patients to be hypercoagulable on day 1 post burn based on 
specific coagulation factor assays, such as tissue plasminogen activator and 
thrombin-antithrombin III complex. However they only analysed results on day 1 and 
7 and did not present baseline results, and did not compare with routine coagulation 
markers [5]. After 5-7 days, Df appeared to be increasing and was found to be in the 
lower range of normal limits. This was comparable to the routine markers, which 
were normal at day 5-7, and also previous literature, which demonstrated a 
normalized coagulation profile 1 week post burn [1,21]. Comparison of Df against 
routine laboratory coagulation markers demonstrated that during the 
hypocoagulable phase, PT and platelet count were within normal limits, with APTT 
just above the normal range, despite a significant reduction in Df. There were a 
significantly higher proportion of patients in the case group (86%) compared to the 
control group (63%) with a positive D-dimer result, indicating both increased clot 
activity and breakdown in the case group.  D-dimer has previously been shown to be 
increased in the early post burn period, with levels normalizing by one-week post 
burn, which was also seen in this study [23]. Apart from APTT at 24hrs post burn, all 
other markers were within the normal range for the duration of the study period. 
This suggests a lack of sensitivity of these standard markers of coagulation to 
hypocoagulable changes seen in burn patients. The MCF from the ROTEM data, 
mirrored the changes in Df over the four time periods, however, although it 
demonstrated reduced clot firmness after 24-hours, this was still within normal 
limits, compared to Df at 24-hours which was significantly below the normal range 
for a healthy clot. This suggests that ROTEM may not be sensitive enough to as 
identify the production of a poor clot structure in the early post burn period. 
Although there was a significant reduction in platelet count after 24 hours in the 
case group, the findings in this chapter also showed a significant decrease in platelet 
activity over the same time period. The platelet count dropped to the lower end of 
normal at 24 hours, whereas the platelet aggregation was initially lower than the 
normal range at presentation, decreased further over 24 hours and then had 
returned to within normal levels by 5 – 7 days, which was associated with a normal 
platelet count that had reached above baseline levels after one week. This data 
supports the findings of previous literature that platelet count is typically within 
normal range at presentation but then decreases within 3 days and has returned to 
near normal within one week [24,25].  
 
Fibrinogen levels were within normal limits at admission, and remained at a similar 
level during the hypocoagulable phase, when Df was significantly reduced. This 
indicates that despite normal concentrations of fibrinogen in burns patients, there is 
reduced organisation of the fibrin microstructure, leading to weak and porous clots, 
demonstrated by a low Df. This study confirms previous findings that measuring the 
physical properties of fibrin polymerisation and how the clot is organised, gives a 
more useful and functional indication of the quality of the clot than a simple 
measure of the fibrinogen concentration available [13,14,16].   
 
The inflammatory response to burns is widely reported and well known, and has 
been inherently linked to coagulation changes [1,3,20]. The extent of the 
inflammatory response has been associated with the size and severity of the burn 
[18]. In this study, despite increased inflammatory response seen, there was a 
significant reduction in Df at 24 hours post burn. This could be partly down to the 
fact burn patients require large volumes of fluid resuscitation in the first 24-36 
hours. Previous in vitro studies have shown that fluid dilution has a significant effect 
on reducing clot microstructure, with colloids having more of an effect than the 
same dilution of crystalloids [13]. This demonstrated the effect wasn’t purely 
dilutional, but due to the intrinsic properties of colloids that have an inhibitory effect 
on fibrin polymerization [12,13,26]. In this study, the lowest recorded values for Df 
(1.39) were comparable to the in vitro results achieved following 60% dilution of 
whole blood with albumin. The protocol for fluid resuscitation in the study centre is 
Parkland formula for the first eight hours post burn, then switching to the Albumin 
based Muir & Barclay resuscitation formula. This switch to Albumin resuscitation 
during the first 24 hours may play a part in the reduction in Df seen over this period, 
as demonstrated in Figure 2. This could potentially lead to increased risk of blood 
loss during early excisional surgery, performed during the resuscitation phase, when 
using Albumin. However, firm conclusions cannot be made based on the size of this 
study. 
 
It appears that the changes in Df are small, ranging from 1.39 to 1.88 in this study, 
however it is important to remember that Df has a non-integer value with a non-
linear relationship with the amount of fibrin mass incorporated within the incipient 
clot (Figure 4). This means that substantial increases in mass are required to 
generate small changes in Df [27,28]. This modelling indicated that after 24 hours (Df 
= 1.59), the incipient clot had a fibrin mass of less than 20% of that incorporated into 
that formed at baseline. For the highest values of Df observed in this study (Df = 
1.88), computer modelling indicated a corresponding 450% increase in fibrin mass 
incorporated into the clot, whereas for the lowest values (Df = 1.39), the incipient 
clot had a fibrin mass of less than 5% of that incorporated into a healthy clot. 
 
Two further factors, which could potentially influence changes in Df, were 
investigated; comorbidities including cardiac, respiratory, or chronic inflammatory 
conditions such as inflammatory bowel disease and rheumatoid arthritis and the 
regular use of either Aspirin or Clopidogrel medication. Patients with significant co-
morbidities had a lower mean Df on admission compared to those without (1.69 
versus 1.73, p = 0.11) and patients who were already taking either Aspirin or 
Clopidogrel had a lower mean Df than those without (1.69 versus 1.73, p = 0.27), 
although neither reached significance. The numbers in the co-morbidities group (n = 
13) and the Aspirin/Clopidogrel groups (n = 8) were small and so little can be gained 
from this data. 
 
This study has several limitations. Firstly this was a single-centre case-controlled 
proof of concept study, and was not powered to generate any clinical outcome data. 
Furthermore, it was outside the scope of this study to seek mechanistic conclusions 
to the studies findings.  Like other similar studies before, the inherent problem of 
this study is the heterogeneity seen in burns, its treatment, concomitant 
medications and co-morbidities. To assess these effects fully and to build on the 




This is the first study to quantify the changes in clot microstructure following burn 
injury. On presentation, Df was not significantly associated with TBSA burnt. This 
study confirms that clot quality is significantly altered during the first 24 hours post 
burn, with the production of a weaker, more porous fibrin clot, consistent with a 
hypocoagulable state, which wasn’t identified with other current markers of 
coagulation. Larger studies are required to investigate the factors that determine 
these changes in clot microstructure and also to investigate the affect of treatment 
on clot quality and clinical outcome. 
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Legends for figures 
 
Figure 1: Differences in standard coagulation markers and Df in the case group, over 
the four time points (0 = Baseline, 1 = 6-12hours, 2 = 24hours, 3 = 5-7 days). Data 
represented as means ± standard deviation error bars (*denotes significance change 
from baseline p<0.05 using one-way ANOVA). Normal ranges are demonstrated 
between dotted lines. 
 
Figure 2: Comparison of the changes in Df alongside the total volume of fluid (ml) 
given (above) and colloid (below) in the case group over the four time periods. Df 
reported as mean ± SD and fluid volume represented as median. Dashed line 
represents the normal range for Df. 
 
Figure 3: Representative SEM images of fully formed clots taken from the same 
patient, at different time points. The micrograph scale bar in the left hand image 
applies to all images and is 10μm long. 
 
Figure 4: Computational analysis of a fibrin mass curve, illustrating the non-linear 
relationship between the fibrin mass incorporated into the developing clot and Df. 
Mass, represented on the y-axis is normalised to the baseline Df of the case group 
(1.72). The following results of Df were put into the model: Df = 1.72 (baseline for the 
case group), Df = 1.59 (case group after 24 hours), Df = 1.69 (case group at 5 – 7 
days). 
 
 
 
 
 
